SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Walsh who wrote (1348)5/17/1999 8:46:00 AM
From: Bob Walsh  Read Replies (1) of 1510
 
It looks like there is some initial panic over this news. I may be wrong, but I believe that this is the acceptance of what had been previously been suspected - that HAART usage would effect the outcome of the study. More complete analysis by those in the field is needed since I am no expert. REMUNE apparently still may a place in the treatment of HIV and it still has potential uses in the variety of other immune diseases.

Regards,
Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News